Literature DB >> 2250886

Meibomian therapy in problematic contact lens wear.

J R Paugh1, L L Knapp, J R Martinson, M M Hom.   

Abstract

Utilizing the principal diagnostic criterion of an absent or cloudy Meibomian gland secretion upon repeated expression, patients with Meibomian gland dysfunction (MGD) were selected to participate in a study of the efficacy of lid scrubs and massage in the treatment of MGD. Twenty-one patients with contact lens intolerance unrelated to lens, care system, or health factors were randomly assigned to treatment of one eye with common clinical therapy for MGD. After 2 weeks of treatment, gland expression, biomicroscopy, staining, comfort, and fluorescein breakup time were assessed in a masked manner. Analyzed using a paired-data t-test, the results indicated a significant increase in mean tear film breakup time (BUT) in the treated eye at follow-up compared to baseline (mean increase = 4.0 s, p = 0.0001). The control eye demonstrated no significant change (mean increase = 0.2 s, p = 0.5955). These objective results were corroborated by reports of improved subjective comfort with contact lens wear after therapy.

Entities:  

Mesh:

Year:  1990        PMID: 2250886     DOI: 10.1097/00006324-199011000-00002

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  14 in total

Review 1.  [Correct contact lens hygiene].

Authors:  S Blümle; T Kaercher; R Khaireddin
Journal:  Ophthalmologe       Date:  2013-06       Impact factor: 1.059

2.  [Meibomian glands : part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

Review 3.  The international workshop on meibomian gland dysfunction: report of the clinical trials subcommittee.

Authors:  Penny A Asbell; Fiona J Stapleton; Kerstin Wickström; Esen K Akpek; Pasquale Aragona; Reza Dana; Michael A Lemp; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 4.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.

Authors:  Debra A Schaumberg; Jason J Nichols; Eric B Papas; Louis Tong; Miki Uchino; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 6.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

7.  Compliance and Subjective Patient Responses to Eyelid Hygiene.

Authors:  Yousef A Alghamdi; Andrew Camp; William Feuer; Carol L Karp; Sarah Wellik; Anat Galor
Journal:  Eye Contact Lens       Date:  2017-07       Impact factor: 2.018

8.  [Meibomian glands : part III. Dysfunction - argument for a discrete disease entity and as an important cause of dry eye].

Authors:  E Knop; N Knop; H Brewitt; U Pleyer; P Rieck; B Seitz; F Schirra
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

9.  Conservative treatment for late-onset bleb leaks after trabeculectomy with mitomycin C in patients with ocular surface disease.

Authors:  Hideto Sagara; Tomohiro Iida; Kimimori Saito; Hiroki Noji; Masashi Ogasawara; Hiroshi Oyamada
Journal:  Clin Ophthalmol       Date:  2012-08-08

10.  New Eye Cleansing Product Improves Makeup-Related Ocular Problems.

Authors:  Masako Okura; Motoko Kawashima; Mikiyuki Katagiri; Takuji Shirasawa; Kazuo Tsubota
Journal:  J Ophthalmol       Date:  2015-08-11       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.